Page 258 - Eshre Final Programme 2015
P. 258
P-587 Pregnancy outcomes in women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF)
L. Sterling1, J. Liu2, A. Sakhuja1, S. Sierra3, N. Okun4, E. Greenblatt5
1University of Toronto, Obstetrics & Gynecology, Toronto, Canada
2University of Toronto, Medical School, Toronto, Canada
3University of Toronto, LifeQuest Centre for Reproductive Medicine, Toronto, Canada 4University of Toronto, Division of Maternal-Fetal Medicine, Toronto, Canada 5University of Toronto, Centre for Fertility & Reproductive Health, Toronto, Canada
P-588 Elective single embryo transfer (eSET) in United States IVF clinics
A. Mancuso1, S. Boulet2, H. Duran1, E. Munch1, D. Kissin2, B. Van Voorhis1
1University of Iowa Carver College of Medicine, Obstetrics and Gynecology, Iowa City, U.S.A. 2Centers for Disease Control and Prevention, Division of Reproductive Health, Atlanta, U.S.A.
P-589 Comparison of monozygotic twinning incidence following Day 5 blastocyst vs. cleavage-stage single embryo transfer (SET) during IVF/ICSI cycles
R. Shaikh1, A. Shamsa2, C. Sjoblom1
1Westmead IVF centre, Sydney University, Westmead, Australia 2Westmead IVF centre, Obstertrics and Gynaecology, Westmead, Australia
P-590 Maternal and perinatal outcomes in oocyte donation pregnancies in Sweden 2003-2012
A. Thurin-Kjellberg1, S. Nejdet1, K. Källén2, U.B. Wennerholm1
1Sahlgrenska University Hospital, Dept. of Ob/Gyn, Göteborg, Sweden 2Tornblad Institute, Dept. of Repr. Epidemiology, lund, Sweden
P-591 Volatile Organic Compounds (VOCs) that are persistently present inside and outside of the In Vitro Fertilization (IVF) laboratories. A 5 years evolution study.
V. Vásquez1, J.L. Romero1, J.M. De Los Santos1, F. Insúa1, S. Pérez1, C. Albert1, P. Gámiz1, T. Viloria1, A. Galán1, M.J. De Los Santos1
1IVI Valencia, IVF Laboratory, Valencia, Spain
P-592 A randomized controlled trial of natural versus artificial cycle for frozen thawed embryo transfer.
E.R. Groenewoud1, N.S. Macklon2, B.J. Cohlen3
1Medical Centre Leeuwarden, Obstetrics and Gynaecology, Leeuwarden, The Netherlands
2University of Southampton. Faculty of Medicine Division of Human Development and Health., Department of Obstetrics and Gynaecology, Southampton, United Kingdom
3Isala Clinic, Fertility Centre Isala, Zwolle, The Netherlands
P-593 Analysis of Day 3 versus Day 5 transfer data from the HFEA Database and a survey of eSET and blastocyst transfer policies in the UK
E.D.M. Kritioti1, J.C. Harper1
1Institute for Women's Health, Women's Health, London, United Kingdom
258


































































































   256   257   258   259   260